Ignite Creation Date:
2024-05-06 @ 10:45 AM
Last Modification Date:
2024-10-26 @ 12:35 PM
Study NCT ID:
NCT03343054
Status:
COMPLETED
Last Update Posted:
2023-09-21
First Post:
2017-11-11
Brief Title:
A Phase 1 Study Of Talazoparib PARP Inhibitor In Japanese Patients With Advanced Solid Tumors
Sponsor:
Pfizer
Organization:
Pfizer